These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35926360)

  • 21. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic accuracy of the Montreal Cognitive Assessment in inpatient stroke rehabilitation.
    Jaywant A; Toglia J; Gunning FM; O'Dell MW
    Neuropsychol Rehabil; 2019 Sep; 29(8):1163-1176. PubMed ID: 28920528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Montreal Cognitive Assessment is a valid cognitive screening tool for cardiac arrest survivors.
    van Gils P; van Heugten C; Hofmeijer J; Keijzer H; Nutma S; Duits A
    Resuscitation; 2022 Mar; 172():130-136. PubMed ID: 34958880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
    Ribeiro M; Durand T; Roussel M; Feuvret L; Jacob J; Psimaras D; Noel G; Keller A; Bompaire F; Hoang-Xuan K; Bernier MO; Godefroy O; Ricard D
    J Neurooncol; 2020 Jun; 148(2):335-342. PubMed ID: 32415644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.
    O'Caoimh R; Timmons S; Molloy DW
    J Alzheimers Dis; 2016; 51(2):619-29. PubMed ID: 26890758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke.
    Potocnik J; Ovcar Stante K; Rakusa M
    Acta Neurol Belg; 2020 Jun; 120(3):681-685. PubMed ID: 32193731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the optimal neuropsychological test battery for schizophrenia in China?
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2019 Jun; 208():317-323. PubMed ID: 30718121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington's disease.
    Aiello EN; Solca F; Torre S; Lafronza A; Maranzano A; Bonetti R; Scheveger F; Maffi S; Ceccarelli C; Scocchia M; Casella M; Verde F; Migliore S; Silani V; Ticozzi N; Squitieri F; Ciammola A; Poletti B
    Neurol Sci; 2024 Mar; 45(3):1079-1086. PubMed ID: 37770762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
    Tian R; Guo Y; Ye P; Zhang C; Luo Y
    PLoS One; 2020; 15(1):e0227073. PubMed ID: 31917792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of extent and pattern of neurocognitive functions in mild and moderate traumatic brain injury patients by using Montreal Cognitive Assessment (MoCA) score as a screening tool: An observational study from India.
    Panwar N; Purohit D; Deo Sinha V; Joshi M
    Asian J Psychiatr; 2019 Mar; 41():60-65. PubMed ID: 30396805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Validation of the Montreal Cognitive Assessment (MoCA) as a screening tool for mild cognitive impairment in the population of Buenos Aires, Argentina].
    González Palau F; Berrios W; García Basalo MM; Ojea Quintana M; Fernández M; García Basalo MJ; Fernández MC; Cámpora N; Matusevich LD; Golimstok Á
    Vertex; 2018 Jul; XXIX(140):261-269. PubMed ID: 30778419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment.
    Thomann AE; Berres M; Goettel N; Steiner LA; Monsch AU
    Alzheimers Res Ther; 2020 Apr; 12(1):39. PubMed ID: 32264975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls.
    Dautzenberg G; Lijmer J; Beekman A
    Int J Geriatr Psychiatry; 2020 Mar; 35(3):261-269. PubMed ID: 31650623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA).
    Wu C; Dagg P; Molgat C
    Schizophr Res; 2014 Sep; 158(1-3):151-5. PubMed ID: 25092174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometrics and diagnostic properties of the Montreal Cognitive Assessment 5-min protocol in screening for Mild Cognitive Impairment and dementia among older adults in Tanzania: A validation study.
    Masika GM; Yu DSF; Li PWC; Wong A; Lin RSY
    Int J Older People Nurs; 2021 Jan; 16(1):e12348. PubMed ID: 32920984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of the Montreal Cognitive Assessment in Detecting Mild Cognitive Impairment and Dementia in the Rural African Population.
    Masika GM; Yu DSF; Li PWC
    Arch Clin Neuropsychol; 2021 Apr; 36(3):371-380. PubMed ID: 31942599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Montreal Cognitive Assessment in a Greek sample of patients with multiple sclerosis: A validation study.
    Konstantopoulos K; Vogazianos P
    Appl Neuropsychol Adult; 2021; 28(1):48-52. PubMed ID: 30939943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.